Danish pharmaceutical group Lundbeck appointed on Tuesday Ulf Wiinberg as its new President and Chief Executive Officer.
Wiinberg comes from Wyeth, where he was president of the company's operations in Europe, Middle East, Africa and Canada, as well as being responsible for its biopharma activities.
His main task will be to find a new cash cow for Lundbeck, whose patents for blockbuster antidepressant Cipralex/Lexapro expire between 2012 and 2014.
Reuters
No comments:
Post a Comment